Lantern Pharma Inc.

NASDAQ:LTRN

3.42 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 0000.2610000000000000000000
Kosten van de omzet 00.0460.0040.0440.0430.0440.0430.0390.0390.0390.0380.07100.0260.00100000000
Brutowinst 0-0.046-0.0040.217-0.043-0.044-0.043-0.039-0.039-0.039-0.038-0.0710-0.026-0.00100000000
Brutowinstmarge 0000.830000000000000000000
Onderzoek- en ontwikkelingskosten 3.7173.8894.2513.5732.213.5582.5532.2520.7022.9892.662.1622.9641.1651.2791.3480.6010.1570.1370.1770.2280.3610.186
Algemene en administratieve kosten 1.4631.521.4811.3041.3141.6321.7331.5751.4431.4061.4061.3491.1841.3141.1731.5481.1010.6760.340.4980.4410.2680.268
Verkoop- en marketingkosten 0-0.046-0.004-0.0440000000000000000000
Verkoop-, algemene en administratieve kosten 1.4631.4731.4771.261.3141.6321.7331.5751.4431.4061.4061.3491.1841.3141.1731.5481.1010.6760.340.4980.4410.2680.268
Overige kosten 00.260.090.4240.1160.3260.2850.37-0.172-0.153-0.0780.0280.0180.115000000000
Bedrijfskosten 5.185.3625.7284.8333.5245.194.2863.8262.1454.3954.0663.5114.1492.4792.4522.8961.7010.8330.4770.6750.670.6290.454
Bedrijfsresultaat -5.18-5.408-5.732-4.877-3.524-5.19-4.286-3.826-2.145-4.395-4.066-3.511-4.149-2.479-2.452-2.896-1.701-0.833-0.477-0.675-0.67-0.629-0.454
Bedrijfsresultaat ratio 000-18.6840000000000000000000
Totaal overige inkomsten en kosten netto 0.6740.4490.2910.6910.1160.3260.4190.445-0.119-0.098-0.0550.0280.0180.1150-5,908.190000000
Inkomen voor belasting -4.506-4.96-5.441-4.186-3.161-4.746-3.868-3.381-2.265-4.492-4.122-3.54-4.054-2.316-2.452-2.896-1.701-0.833-0.477-0.675-0.67-0.629-0.454
Inkomen voor belasting ratio 000-16.0350000000000000000000
Belastingkosten 00-00-0.246-0.118-0.419-0.4450.1190.0980.0550.029-0.077-0.0480-5,908.190000000
Nettowinst -4.506-4.96-5.441-4.186-3.161-4.746-3.449-2.936-2.384-4.59-4.177-3.54-4.054-2.316-2.452-2.896-1.701-0.833-0.477-0.675-0.67-0.629-0.454
Nettowinstmarge 000-16.0350000000000000000000
WPA (Winst Per Aandeel) -0.42-0.46-0.51-0.39-0.29-0.44-0.32-0.27-0.22-0.42-0.38-0.32-0.36-0.21-0.24-0.47-0.27-0.31-0.079-0.11-0.11-0.1-0.073
Verwaterde WPA -0.42-0.46-0.51-0.39-0.29-0.44-0.32-0.27-0.22-0.42-0.38-0.32-0.36-0.21-0.24-0.47-0.27-0.31-0.079-0.11-0.11-0.1-0.073
EBITDA -5.18-5.362-5.728-4.833-3.52-5.187-4.283-3.824-2.142-4.392-4.064-3.509-4.147-2.478-2.451-2.895-1.7-0.833-0.477-0.675-0.669-0.629-0.454
EBITDA ratio 000-18.5140000000000000000000